85 related articles for article (PubMed ID: 9684935)
1. Prognostic markers of disease activity in Hodgkin's disease.
Martinow AJ; Yuen K; Cooper IA; Matthews JP; Juneja S; Wolf M; Januszewicz H; Prince HM
Leuk Lymphoma; 1998 Apr; 29(3-4):383-9. PubMed ID: 9684935
[TBL] [Abstract][Full Text] [Related]
2. Serum lactate dehydrogenase level as a prognostic factor in Hodgkin's disease.
García R; Hernández JM; Caballero MD; González M; Galende J; del Cañizo MC; Vázquez L; San Miguel JF
Br J Cancer; 1993 Dec; 68(6):1227-31. PubMed ID: 8260377
[TBL] [Abstract][Full Text] [Related]
3. Evolution of erythrocyte sedimentation rate as predictor of early relapse in posttherapy early-stage Hodgkin's disease.
Friedman S; Henry-Amar M; Cosset JM; Carde P; Hayat M; Dupouy N; Tubiana M
J Clin Oncol; 1988 Apr; 6(4):596-602. PubMed ID: 3357004
[TBL] [Abstract][Full Text] [Related]
4. Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma.
Bien E; Balcerska A
Scand J Immunol; 2009 Nov; 70(5):490-500. PubMed ID: 19874554
[TBL] [Abstract][Full Text] [Related]
5. Serum copper, serum ceruloplasmin, and erythrocyte sedimentation rate measurements in children with Hodgkin's disease, non-Hodgkin's lymphoma, and nonmalignant lymphadenopathy.
Margerison AC; Mann JR
Cancer; 1985 Apr; 55(7):1501-6. PubMed ID: 3978543
[TBL] [Abstract][Full Text] [Related]
6. New prognostic score based on treatment outcome of patients with relapsed Hodgkin's lymphoma registered in the database of the German Hodgkin's lymphoma study group.
Josting A; Franklin J; May M; Koch P; Beykirch MK; Heinz J; Rudolph C; Diehl V; Engert A
J Clin Oncol; 2002 Jan; 20(1):221-30. PubMed ID: 11773173
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of erythrocyte sedimentation rate in clinical stages I-II of Hodgkin's disease.
Tubiana M; Henry-Amar M; Burgers MV; van der Werf-Messing B; Hayat M
J Clin Oncol; 1984 Mar; 2(3):194-200. PubMed ID: 6366151
[TBL] [Abstract][Full Text] [Related]
8. Serum copper compared to erythrocyte sedimentation rate as indicator of disease activity in Hodgkin's disease.
Asbjörnsen G
Scand J Haematol; 1979 Mar; 22(3):193-6. PubMed ID: 451449
[TBL] [Abstract][Full Text] [Related]
9. Soluble ICAM-1 in Hodgkin's disease: a promising independent predictive marker for survival.
Christiansen I; Enblad G; Kälkner KM; Gidlöf C; Glimelius B; Tötterman TH
Leuk Lymphoma; 1995 Oct; 19(3-4):243-51. PubMed ID: 8535215
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of erythrocyte sedimentation rate, C-reactive protein and serum lactate dehydrogenase levels in the diagnosis, prognosis and treatment monitoring of children suffering from cancer].
Bień E; Balcerska A
Med Wieku Rozwoj; 2004; 8(4 Pt 2):1081-9. PubMed ID: 15951603
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the prognostic meaning of C-reactive protein (CRP) in children and adolescents with classical Hodgkin's lymphoma (HL).
Haase R; Vilser C; Mauz-Körholz C; Hasenclever D; Kluge R; Ruschke K; Borkhardt A; Seeger K; Lehrnbecher T; Kulozik A; Rößler J; Burdach S; Jürgens H; Körholz D
Klin Padiatr; 2012 Oct; 224(6):377-81. PubMed ID: 23047832
[TBL] [Abstract][Full Text] [Related]
12. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Hodgkin's disease: a twenty-year follow-up of patients at a center in Korea.
Cheong JW; Park SY; Roh JK; Suh CO; Hahn JS
Yonsei Med J; 2006 Aug; 47(4):455-65. PubMed ID: 16941733
[TBL] [Abstract][Full Text] [Related]
14. Value of serum copper levels and erythrocyte sedimentation rates as indicators of disease activity in children with Hodgkin's disease.
Wilimas J; Thompson E; Smith KL
Cancer; 1978 Oct; 42(4):1929-35. PubMed ID: 709539
[TBL] [Abstract][Full Text] [Related]
15. The serum levels of eosinophil cationic protein (ECP) are related to the infiltration of eosinophils in the tumours of patients with Hodgkin's disease.
Molin D; Glimelius B; Sundström C; Venge P; Enblad G
Leuk Lymphoma; 2001 Jul; 42(3):457-65. PubMed ID: 11699410
[TBL] [Abstract][Full Text] [Related]
16. [Significance of metabolic parameters in Hodgkin's disease (author's transl)].
Oertel J; Gerhartz H
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 Jun; 86(2):185-93. PubMed ID: 59479
[TBL] [Abstract][Full Text] [Related]
17. Image-aided estimate of tumor burden in Hodgkin's disease: evidence of its primary prognostic importance.
Gobbi PG; Ghirardelli ML; Solcia M; Di Giulio G; Merli F; Tavecchia L; Bertè R; Davini O; Levis A; Broglia C; Maffè GC; Ilariucci F; Dore R; Ascari E
J Clin Oncol; 2001 Mar; 19(5):1388-94. PubMed ID: 11230483
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of alkaline phosphatase, gamma-glutamyl transpeptidase and lactate dehydrogenase in hepatocellular carcinoma patients treated with liver resection.
Wu SJ; Lin YX; Ye H; Xiong XZ; Li FY; Cheng NS
Int J Surg; 2016 Dec; 36(Pt A):143-151. PubMed ID: 27793641
[TBL] [Abstract][Full Text] [Related]
19. Value of laboratory indicators in Hodgkin's disease: preliminary results.
Ray GR; Wolf PH; Kaplan HS
Natl Cancer Inst Monogr; 1973 May; 36():315-23. PubMed ID: 4744591
[No Abstract] [Full Text] [Related]
20. Classification and prognostic value of serum copper/zinc ratio in Hodgkin's disease.
Cunzhi H; Jiexian J; Xianwen Z; Jingang G; Suling H
Biol Trace Elem Res; 2001 Nov; 83(2):133-8. PubMed ID: 11762530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]